RA0675

antibody from Oursmab
Targeting: SEMA4D C9orf164, CD100, coll-4, FLJ39737, SEMAJ
Provider product page for RA0675
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0675 - Provider product page
Provider
Oursmab
Product name
Pepinemab (Biosimilar Reference Antibody) (SEMA4D)
Antibody type
Monoclonal
Description
Pepinemab (also known as VX-15/SA-4F) is an investigational, humanized monoclonal antibody that targets semaphorin 4D (SEMA4D, CD100), a transmembrane protein involved in immune regulation and neuronal guidance. SEMA4D is expressed on activated T cells, B cells, and dendritic cells, and its receptor plexin-B1 is found on endothelial cells, neurons, and immune cells. By binding to SEMA4D, pepinemab blocks its signaling, thereby inhibiting the negative regulatory effects of SEMA4D on immune cell infiltration and activation in the tumor microenvironment. This promotes the recruitment and function of cytotoxic T cells and reduces immunosuppressive cells. It is being developed as an immuno-oncology agent for the treatment of advanced solid tumors, including head and neck squamous cell carcinoma (HNSCC) and glioblastoma.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
SEMA4D protein structure - RA0675 shown in red.